Wondering if Thermo Fisher Scientific at around US$472.95 is offering good value right now, or if the stock has already run ahead of itself. The share price has been mixed recently, with a 1.4% gain over the last 7 days, a 3.1% decline over the last 30 days, and a 20.2% decline year to date, even though the 1 year return sits at 16.4%. These moves come against a backdrop of ongoing attention on Thermo Fisher Scientific as a major supplier of life sciences tools and services, with investors...

By Karen Roman Agilent Technologies, Inc. (NYSE: A) said it designated Michael Buckner as Chief Legal Officer, having previously served at Danaher as Vice President, Deputy General Counsel, and Chief M&A Counsel. Mr. Buckner has nearly 30 years of experience as a senior global legal executive with experience in complex transactions and regulatory environments, the […]

Alphabet rides AI-driven growth across Search, Cloud and subscriptions, but rising spending, debt and legal risks temper near-term flexibility.

Examine Thermo Fisher's (TMO) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

Today we're going to take a look at the well-established Thermo Fisher Scientific Inc. ( NYSE:TMO ). The company's...

Hedge fund billionaire Daniel Loeb assumed a stake in the Life Sciences Tools & Services company Thermo Fisher Scientific Inc at Third Point LLC in the fourth quarter of FY25. As of Dec. 31, 2025, Loeb bought 50,000 shares in the company. Recent Key Events In February, Thermo Fisher Scientific’s Board approved a quarterly dividend of $0.47 per share, payable on April 15, 2026, to shareholders of record as of March 13, 2026. The new dividend represents a 10% increase from the prior $0.43 payout.

Thermo Fisher Scientific recently opened its flagship U.S. Bioprocess Design Center at its Plainville, Massachusetts site, expanding by 4,000 square feet to offer end-to-end bioproduction workflow support for biologics, vaccines, and cell and gene therapies alongside hands-on customer training. This new center integrates Thermo Fisher’s bioprocess expertise with its existing 290,000-square-foot sterile fill-finish and viral vector facility, reinforcing its role as a comprehensive partner...

Corning (GLW) reported Q1 2026 core sales of $4.35 billion, representing an 18% year-over-year increase. The core insight hiding beneath this headline beat is how entirely the AI-driven acceleration is offsetting the more modest growth currently seen in the company's traditional Glass Innovations segment.

Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here. Baron Health Care Fund (the Fund) declined 6.97% (Institutional Shares) in the quarter, compared to the 4.88% decline for the Russell 3000 Health Care Index (the Benchmark) and […]

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.